New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
14:41 EDTPACB, ILMN, LMNX, DGX, LH, VCYT, SQNM, QGEN, MYGN, GHDXFDA draft lab tests guidelines not as bad as feared, says Piper Jaffray
After the FDA announced it intends to issue draft guidance on regulations for lab developed tests, Piper Jaffray said the proposed guidelines appear "less onerous" than the firm initially expected. Piper added that the FDA intends to leverage existing studies in lieu of requiring additional studies, which the firm views as positive for companies with well validated offerings such as Genomic Health (GHDX), Myriad Genetics (MYGN), QIAGEN (QGEN), Sequenom (SQNM), and Veracyte (VCYT).
News For GHDX;MYGN;QGEN;SQNM;VCYT;DGX;ILMN;LH;LMNX;PACB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
07:48 EDTILMNFluidigm, Illumina single cell opportunities compelling, says Leerink
Subscribe for More Information
July 1, 2015
09:35 EDTILMNIllumina price target raised to $300 from $264 at Cowen
Subscribe for More Information
June 30, 2015
19:32 EDTDGXQuest to acquire MemorialCare's laboratory outreach service business
Quest Diagnostics and MemorialCare Health System announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System's laboratory outreach service business. The transaction is expected to be neutral to earnings in 2015. Quest and MemorialCare Health System expect to complete the acquisition in August. Financial terms were not disclosed.
07:56 EDTSQNMACOG opinion on NIPT not as bullish as hoped for Sequenom, says William Blair
Subscribe for More Information
June 25, 2015
17:03 EDTVCYTVeracyte signs national network agreement with Aetna
Subscribe for More Information
09:27 EDTILMNLeerink life science tools analyst holds an analyst/industry conference call
Life Science Tools and Diagnostics Dan Leonard, along with Dr. Paul Robson and Dr. Peter Kuhn, discuss the demand for Fluidigm's single cell prep products, including the impact to Biomark and the utility of CyTOF on an Analyst/Industry conference call to be held on July 1 at 2 pm.
09:21 EDTILMNBioMed Realty leases build-to-suit laboratory in Cambridge to Illumina
BioMed Realty (BMR) announced that Illumina ILMN) has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. BioMed Realty acquired the land for the project from The Welding Institute under a long term ground lease, enlarging BioMed Realty's Granta Park campus in Cambridge, England.
June 24, 2015
17:26 EDTVCYTVeracyte files to sell 5M shares of common stock for holders
Subscribe for More Information
17:25 EDTVCYTVeracyte files $125M mixed securities shelf
Subscribe for More Information
07:05 EDTQGENTokai announces start of Phase 3 ARMOR3-SV trial of mCRPC treatment
Subscribe for More Information
June 23, 2015
10:00 EDTDGXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:08 EDTGHDXGenomic Health announces results from study of the Oncotype DX DCIS Score
Subscribe for More Information
07:25 EDTLH, DGXPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
06:13 EDTDGXQuest Diagnostics downgraded to Neutral from Buy at Goldman
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use